Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Downgrades Paya Holdings to Neutral

BTIG Downgrades Paya Holdings to Neutral

BTIG analyst Mark Palmer downgrades Paya Holdings (NASDAQ:PAYA) from Buy to Neutral.

byBenzinga Newsdesk

January 10, 2023

1 minute read

BTIG analyst Mark Palmer downgrades Paya Holdings (NASDAQ:PAYA) from Buy to Neutral.

November’s Xbox Game Pass Lineup: Master Headbangers, Jusant, Wartales, More

By Franca Quarneti

November 1, 4:01 PM

Microsoft Corporation (NASDAQ: MSFT) has revealed the initial lineup of games coming to Xbox Game Pass in November 2023, taking subscribers up to Nov.

MSFT

Analyst Ratings

Where Eastman Chemical Stands With Analysts

By Benzinga Insights

April 11, 5:00 PM

Analysts have provided the following ratings for Eastman Chemical (NYSE:EMN) within the last quarter: Bullish Somewhat Bullish Indifferent…

EMN

Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024

By Vandana Singh

December 28, 10:21 AM

2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations.

AZN

Enovis Receives FDA Approval Of Patient Specific Instrumentation For STAR Ankle

By Benzinga Newsdesk

December 1, 10:07 AM

Enovis Corporation (NYSE:ENOV), an innovation-driven medical technology company, announced that the U.S. Food and Drug Administration (FDA) has approved the STAR Patient Specific Instrumentation (STAR PSI System)

ENOV

BTIG Downgrades Paya Holdings to Neutral

Related Posts

November’s Xbox Game Pass Lineup: Master Headbangers, Jusant, Wartales, More

Where Eastman Chemical Stands With Analysts

Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024

Enovis Receives FDA Approval Of Patient Specific Instrumentation For STAR Ankle